Vaccine-enhanced competition permits rational bacterial strain replacement in the gut
Authors:
- Verena LentschVLVerena Lentsch
- Andrea RockerARAndrea Rocker
- Claudia MoresiCMClaudia Moresi
- Louise LarssonLLLouise Larsson
- Stefan A. FattingerSFStefan A. Fattinger
- Nicolas WennerNWNicolas Wenner
- Elisa Cappio BarazzoneEBElisa Cappio Barazzone
- Wolf-Dietrich HardtWHWolf-Dietrich Hardt
- Claude LoverdoCLClaude Loverdo
- 4 April 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6742) , 74-81
Abstract
Colonization of the intestinal lumen precedes invasive infection for a wide range of enteropathogenic and opportunistic pathogenic bacteria. We show that combining oral vaccination with engineered or selected niche-competitor strains permits pathogen exclusion and strain replacement in the mouse gut lumen. This approach can be applied either prophylactically to prevent invasion of nontyphoidal Salmonella strains, or therapeutically to displace an established Escherichia coli. Both intact adaptive immunity and metabolic niche competition are necessary for efficient vaccine-enhanced competition. Our findings imply that mucosal antibodies have evolved to work in the context of gut microbial ecology by influencing the outcome of competition. This has broad implications for the elimination of pathogenic and antibiotic-resistant bacterial reservoirs and for rational microbiota engineering.Keywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Differences in carbon metabolic capacity fuel co-existence and plasmid transfer between Salmonella strains in the mouse gutCell Host & Microbe, 2023
- Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationCell, 2022
- E. coli enhance colonization resistance against Salmonella Typhimurium by competing for galactitol, a context-dependent limiting carbon sourceCell Host & Microbe, 2021
- Current Stage in the Development of Klebsiella pneumoniae VaccinesInfectious Diseases and Therapy, 2021
- Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved HealthThe American Journal of Pathology, 2019
- Antibiotic Treatment Selects for Cooperative Virulence of Salmonella TyphimuriumCurrent Biology, 2014
- Microbiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of the Gut EcosystemCell Host & Microbe, 2013
- Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinantGene, 1995
- ColE1-type vectors with fully repressible replicationGene, 1991
- [2] Bacteriophage-mediated generalized transduction in Escherichia coli and Salmonella typhimurium1991